Supervised exercise training and increased physical activity to reduce cardiovascular disease risk in women with polycystic ovary syndrome: Study protocol for a randomized controlled feasibility trial [PDF]
, 2020 Background: Polycystic ovary syndrome (PCOS) affects up to 20% of women and is characterised by higher amounts of visceral fat, obesity, insulin resistance, dyslipidemia and reproductive and cardiometabolic complications.
Broom, David +4 more
core +2 more sources
The Place of In Vitro Maturation in PCO/PCOS [PDF]
International Journal of Endocrinology, 2018 In vitro maturation (IVM) of human oocytes is an emerging treatment option for women with polycystic ovary/polycystic ovary syndrome (PCO/PCOS) in addition to the standard in vitro fertilization (IVF) treatment. There has been significant improvements in pregnancy rates with IVM over the last two decades. This article reviews the place of IVM for women
Shital Julania +2 more
openaire +3 more sources
Journal of Obstetrics and Gynaecology, 2023 Circular RNAs are involved in the pathogenesis of various diseases, although its expression pattern and role in polycystic ovary syndrome (PCOS), characterised by hyperandrogenism, are not very clear. This article assessed the circRNAs expression profile
Xueying Zhang +5 more
doaj +1 more source
Rodent Models of Polycystic Ovary Syndrome [PDF]
, 2013 Rodents are clearly valuable models for assessing disruption of fertility. The effects of different steroid treatments at different stages of reproductive life through from fetal to adult have been assessed for effects on fertility, ovarian morphology ...
Duncan, Colin, McNeilly, Alan S
core +1 more source
The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study [PDF]
, 2004 To evaluate the cardiovascular risk of polycystic ovary syndrome (PCOS), we investigated lipid profile, metabolic pattern, and echocardiography in 30 young women with PCOS and 30 healthy age- and body mass index (BMI)-matched women. PCOS women had higher
CASCELLA, TERESA +7 more
core +1 more source
Polycystic ovary syndrome (PCOS) - risk factor, diagnostic and current treatment
Journal of Education, Health and Sport, 2020 Introduction: Polycystic ovary syndrome (PCOS) is one of the most common endocrine and metabolic disorders in women in reproductive age, defined as a combination of signs and symptoms resulting from androgen excess and ovarian dysfunction in the absence
Justyna Wojcik +5 more
doaj +1 more source
Developmental and functional effects of steroid hormones on the neuroendocrine axis and spinal cord [PDF]
, 2016 This review highlights the principal effects of steroid hormones at central and peripheral levels in the neuroendocrine axis. The data discussed highlight the principal role of oestrogens and testosterone in hormonal programming in relation to sexual ...
Gonzalez Deniselle, Maria Claudia +4 more
core +2 more sources
ASSOCIATION OF SERUM AMH WITH LABORATORY AND PHENOTYPE IN WOMEN WITH PCOS: A RETROSPECTIVE STUDY
Sabiad, 2023 Objective: The aim of this study was to compare the endocrine and phenotypic characteristics of PCOS women with serum AMH levels of 4‑10 ng/mL and >10 ng/mL, and to investigate the importance of high AMH levels in the diagnosis of PCOS.
Özlem Karabay Akgül +1 more
doaj +1 more source
The experiences of women with polycystic ovary syndrome on a very low-calorie diet [PDF]
, 2016 The research was funded by an educational grant from LighterLife. Broom was the Medical Director for LighterLife at the time of the research. Johnson is the Head of Nutrition and Research at LighterLife.
Broom, John +5 more
core +3 more sources
Journal of Clinical & Translational EndocrinologyThe subject of polycystic ovary syndrome (PCOS) has been extensively covered in the literature; however, there is a paucity of data regarding eumenorrheic women with hyperandrogenism and/or hyperandrogenemia without ultrasound evidence of PCO morphology (
Salvatore Benvenga +3 more
doaj +1 more source